Host-Pathogen Interactions
"Host-Pathogen Interactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The interactions between a host and a pathogen, usually resulting in disease.
| Descriptor ID |
D054884
|
| MeSH Number(s) |
G06.380 G16.543
|
| Concept/Terms |
Host-Pathogen Interactions- Host-Pathogen Interactions
- Host Pathogen Interactions
- Host-Pathogen Interaction
- Interaction, Host-Pathogen
- Interactions, Host-Pathogen
- Pathogen-Host Interactions
- Interaction, Pathogen-Host
- Interactions, Pathogen-Host
- Pathogen Host Interactions
- Pathogen-Host Interaction
- Host-Pathogen Relations
- Host Pathogen Relations
- Host-Pathogen Relation
- Relation, Host-Pathogen
- Relations, Host-Pathogen
|
Below are MeSH descriptors whose meaning is more general than "Host-Pathogen Interactions".
Below are MeSH descriptors whose meaning is more specific than "Host-Pathogen Interactions".
This graph shows the total number of publications written about "Host-Pathogen Interactions" by people in this website by year, and whether "Host-Pathogen Interactions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 1 | 2 | 3 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Host-Pathogen Interactions" by people in Profiles.
-
Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus. J Gen Virol. 2024 05; 105(5).
-
PHINDaccess Hackathons for COVID-19 and Host-Pathogen Interaction: Lessons Learned and Recommendations for Low- and Middle-Income Countries. Biomed Res Int. 2023; 2023:6638714.
-
Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma. Front Immunol. 2022; 13:834650.
-
Editorial: The Role of Platelet Activation in the Pathophysiology of HIV, Tuberculosis and Pneumococcal Disease. Front Immunol. 2021; 12:737016.
-
The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. Front Immunol. 2021; 12:661204.
-
The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis. Front Immunol. 2021; 12:623941.
-
Differential Responsiveness of the Platelet Biomarkers, Systemic CD40 Ligand, CD62P, and Platelet-Derived Growth Factor-BB, to Virally-Suppressive Antiretroviral Therapy. Front Immunol. 2020; 11:594110.
-
The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin a4ß7 and promotes cellular activation and infection. Proc Natl Acad Sci U S A. 2020 12 22; 117(51):32566-32573.
-
Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda. Front Immunol. 2020; 11:929.
-
Indoleamine 2, 3-Dioxygenase-Mediated Tryptophan Catabolism: A Leading Star or Supporting Act in the Tuberculosis and HIV Pas-de-Deux? Front Cell Infect Microbiol. 2019; 9:372.